Video Experimental Relacionado
Updated: May 22, 2026
10:29
A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
Ampliar las intervenciones para lograr el control mundial de la tuberculosis: progreso y nuevos desarrollos
Mario Raviglione1, Ben Marais, Katherine Floyd
1STOP TB Department, WHO, Geneva, Switzerland.
Lancet (London, England)
|May 22, 2012
Resumen
Los esfuerzos mundiales de control de la tuberculosis están progresando, acercándose a los Objetivos de Desarrollo del Milenio, pero persisten desafíos como la colaboración entre el VIH / tuberculosis y la resistencia a los medicamentos. La inversión continua y los enfoques multidisciplinarios son vitales para la eliminación de la tuberculosis.
Área de la Ciencia:
- Salud Global La salud global.
- Enfermedades infecciosas Enfermedades infecciosas.
- Política de salud pública Política de salud pública.
Sus antecedentes:
- La tuberculosis (TB) sigue siendo una causa significativa de mortalidad en todo el mundo.
- Las revisiones anteriores destacaron los esfuerzos y desafíos de control.
- Se ha avanzado hacia los objetivos de 2015, con África como excepción.
Objetivo del estudio:
- Revisar los avances recientes en los esfuerzos mundiales de control de la tuberculosis.
- Identificar los desafíos actuales y las amenazas emergentes en el control de la TB.
- Hacer hincapié en la necesidad de estrategias actualizadas y compromiso sostenido.
Principales métodos:
- Revisión de los recientes datos e iniciativas mundiales de control de la tuberculosis.
- Análisis del progreso hacia los Objetivos de Desarrollo del Milenio y los objetivos de Stop TB Partnership.
- Evaluación de los desafíos, incluida la colaboración TB / VIH, la resistencia a los medicamentos y los impactos de las enfermedades no transmisibles.
Principales resultados:
- La mayoría de las regiones están en camino de cumplir con los objetivos de reducción de la incidencia y la mortalidad por tuberculosis para 2015, excepto África.
- Los desafíos persisten en la ampliación de las actividades de colaboración entre la TB y el VIH.
- La tuberculosis emergente resistente a los medicamentos plantea una amenaza significativa.
- Nuevas pruebas de diagnóstico y medicamentos prometedores están llegando a estar disponibles.
- Las enfermedades no transmisibles y las malas condiciones de vida aumentan la vulnerabilidad.
Conclusiones:
- El logro de los objetivos internacionales de control de la TB requiere políticas y servicios de salud nacionales óptimos.
- La inversión continua en nuevos enfoques y estrategias es crucial.
- La incertidumbre financiera y los déficits ponen en riesgo las ganancias recientes.
- La perseverancia y el compromiso renovado son esenciales para el control y la eliminación de la TB.
Más Videos Relacionados
Videos de Conceptos Relacionados
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:25Transmission-based Precautions II: Airborne and Protective Environment
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...